JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RFP
3701
DELISTED
Resolute Forest Products Inc.
RFP
| $485K | ﹤0.01% |
229,849
-142,959
| -38% | -$271K |
2013 Q2
28 quarters
|
|
3702
Magnachip Semiconductor
MX
$129M
| $484K | ﹤0.01% |
46,998
-221,714
| -83% | -$2.47M |
2020 Q1
1 quarter
|
|
|
MTEM
3703
CALL
DELISTED
Molecular Templates, Inc.
MTEM
| $483K | ﹤0.01% |
+2,333
| New | +$542K |
2020 Q2
0 quarters
|
|
3704
Red Violet
RDVT
$1.28B
| $482K | ﹤0.01% |
+27,374
| New | +$512K |
2020 Q2
0 quarters
|
|
|
MNTA
3705
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $482K | ﹤0.01% |
+14,500
| New | +$462K |
2020 Q2
0 quarters
|
|
3706
iShares Agency Bond ETF
AGZ
$631M
| $481K | ﹤0.01% |
3,972
+113
| +3% | +$13.6K |
2020 Q1
1 quarter
|
|
3707
Quince Therapeutics
QNCX
$28.6M
| $481K | ﹤0.01% |
52
-20
| -28% | -$183K |
2019 Q2
4 quarters
|
|
|
TWNKW
3708
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
| – | – |
0
| – | – |
2019 Q4
2 quarters
|
|
3709
Utz Brands
UTZ
$1.27B
| $480K | ﹤0.01% |
35,000
-360,852
| -91% | -$4.18M |
2020 Q1
1 quarter
|
|
3710
First Northwest Bancorp
FNWB
$93.6M
| $479K | ﹤0.01% |
38,659
+24,495
| +173% | +$288K |
2017 Q4
10 quarters
|
|
|
LNW
3711
CALL
DELISTED
Light & Wonder
LNW
| $479K | ﹤0.01% |
31,000
-10,000
| -24% | -$131K |
2019 Q1
5 quarters
|
|
|
CYBE
3712
DELISTED
Cyberoptics Corp
CYBE
| $479K | ﹤0.01% |
14,884
+5,897
| +66% | +$164K |
2019 Q1
5 quarters
|
|
3713
Vanguard Intermediate-Term Treasury ETF
VGIT
$38.7B
| $476K | ﹤0.01% |
6,744
+1,151
| +21% | +$81K |
2016 Q1
17 quarters
|
|
|
DENN
3714
DELISTED
Denny's
DENN
| $475K | ﹤0.01% |
46,964
-94,591
| -67% | -$971K |
2017 Q4
10 quarters
|
|
|
SASR
3715
DELISTED
Sandy Spring Bancorp Inc
SASR
| $475K | ﹤0.01% |
19,132
-108,670
| -85% | -$2.58M |
2015 Q4
18 quarters
|
|
3716
Allot
ALLT
$415M
| $473K | ﹤0.01% |
45,213
-5,687
| -11% | -$60.3K |
2018 Q3
7 quarters
|
|
3717
Minerva Neurosciences
NERV
$159M
| $471K | ﹤0.01% |
16,284
+3,356
| +26% | +$197K |
2017 Q3
11 quarters
|
|
3718
Frontline
FRO
$12B
| $468K | ﹤0.01% |
67,105
-1,971,464
| -97% | -$16.7M |
2013 Q2
28 quarters
|
|
|
TEF
3719
DELISTED
Telefonica
TEF
| $467K | ﹤0.01% |
115,230
+113,583
| +6,896% | +$440K |
2013 Q2
28 quarters
|
|
3720
Veracyte
VCYT
$3.83B
| $467K | ﹤0.01% |
18,045
+2,487
| +16% | +$62K |
2017 Q3
11 quarters
|
|
3721
The Joint Corp
JYNT
$102M
| $463K | ﹤0.01% |
30,325
+26,153
| +627% | +$343K |
2019 Q1
5 quarters
|
|
3722
Madison Square Garden
MSGS
$9.64B
| $463K | ﹤0.01% |
3,155
-28,065
| -90% | -$4.64M |
2013 Q2
28 quarters
|
|
3723
ProShares UltraPro Short S&P 500
SPXU
$403M
| $463K | ﹤0.01% |
392
+327
| +503% | +$498K |
2018 Q4
6 quarters
|
|
|
YELL
3724
CALL
DELISTED
Yellow Corporation Common Stock
YELL
| $463K | ﹤0.01% |
250,000
-19,900
| -7% | -$32.4K |
2019 Q3
3 quarters
|
|
|
JMIA
3725
Jumia Technologies
JMIA
$907M
| $460K | ﹤0.01% |
+83,824
| New | +$386K |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.